Cesar Augusto Santa-Maria, MD | Authors

Obese Breast Cancer Patients and Survivors: Management Considerations

August 15, 2018

This article will present feasible weight loss interventions, and will discuss practical implications of ongoing chemotherapy and endocrine therapy with regard to weight gain, and the impact of obesity on therapy-related conditions during breast cancer survivorship.

Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?

February 15, 2016

This review will summarize the current standard of care; key issues that arise when treating patients with HER2-positive disease; and developments in novel therapeutics, including small-molecule inhibitors, nanoparticles, immunotherapy, and agents targeting resistance pathways.

The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor–Positive Early-Stage Breast Cancer

July 15, 2015

Here, we provide an in-depth review of the current evidence for the addition of ovarian suppression to adjuvant endocrine therapy, and we offer recommendations for clinical management.

Thoughts on the Annual PLATO Fellows Forum in Breast Oncology

May 31, 2014

This morning I attended the Annual PLATO Fellows Forum in Breast Oncology at ASCO. This is a fantastic venue in which oncology trainees can learn about cutting-edge breast cancer management strategies and the frontiers of research.